Liver Cancer
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2007; 13(23): 3164-3170
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3164
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flowchart of study patients.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Increased uptake of 111Indium labeled octreotide in the right hepatic lobe. Somatostatin receptor positive scan.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Survival probabilities in the groups of the study.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Score of the QLQ-C30 during the 12 mo of follow up.
  • Citation: Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D, Paraskevas E. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial. World J Gastroenterol 2007; 13(23): 3164-3170
  • URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3164.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3164